RE: KingH30 Jan 2026 11:51
Apologies....all cut n paste
Specialized Partner: Physiomics uses its Virtual Tumour™ technology to provide PK/PD modelling and simulation, acting as a specialized partner to larger, full-service CROs or directly with pharma companies to guide clinical trials.
Active Collaborations: Physiomics has worked with various organizations, including Cancer Research UK (CRUK), Bicycle Therapeutics, Servier, Merck KGaA, and others, to optimize dosing schedules and improve drug development success.
Expertise Integration: Their team includes experts with backgrounds in major pharma and other CRO companies, enabling them to integrate into broader clinical development programs.
Physiomics is positioned as a specialist collaborator that helps partners (including CROs) optimize preclinical and clinical oncology programs.